
Investors Face August Deadline in Erasca Securities Class Action
Investors who purchased Erasca, Inc. common stock between January 14, 2025, and April 26, 2026, have until August 10 to seek appointment as lead plaintiff in a class action lawsuit. The litigation, filed in the Southern District of California, accuses the oncology company of misleading shareholders regarding its drug development.



























